Literature DB >> 20385066

Impact of RANTES, MCP-1 and IL-8 in mast cells.

M L Castellani, M A De Lutiis, E Toniato, F Conti, P Felaco, M Fulcheri, T C Theoharides, A Caraffa, P Antinolfi, P Conti, C Cuccurullo, C Ciampoli, M Felaco, C Orso, V Salini, G Cerulli, D Kempuraj, S Tetè, B Shaik.   

Abstract

Chemokines are cytokines with chemotactic properties on inflammatory cells and other cell types. RANTES, MCP-1 and related molecules, constitute the C-C class of chemokine supergene family and a group of cytokines produced by hematopoietic cells, while IL-8 constitute the C-X-C class. The roles of most of these chemokines are not well known, although members of the chemokine family are inflammatory agents. The C-C chemokine plays a role in regulating Th-cell cytokine production and leukocyte trafficking. In this study we clearly show that RANTES and MCP-1 are mediators of acute inflammatory responses. Our report describes additional biological activities for RANTES, MCP-1, and IL-8, suggesting that these chemokines play a fundamental role in histamine and serotonin generation and cell function in mast cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20385066

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  15 in total

1.  Inflammatory and Immune Activation in Intestinal Myofibroblasts Is Developmentally Regulated.

Authors:  Sharmila Zawahir; Guanghui Li; Aditi Banerjee; Jessica Shiu; Thomas G Blanchard; Adora C Okogbule-Wonodi
Journal:  J Interferon Cytokine Res       Date:  2015-06-23       Impact factor: 2.607

2.  Up-regulation of chemokine C-C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria.

Authors:  J C Santos; C A de Brito; E A Futata; M H Azor; N M Orii; C W Maruta; E A Rivitti; A J S Duarte; M N Sato
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 3.  Chemokines and chemokine receptors in allergic rhinitis: from mediators to potential therapeutic targets.

Authors:  Zhan Li; Sihua Yu; Yongjun Jiang; Yajing Fu
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-23       Impact factor: 3.236

Review 4.  Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome.

Authors:  Lara Tiranini; Rossella E Nappi
Journal:  Fac Rev       Date:  2022-04-28

5.  Immunomodulatory effects of 17-O-acetylacuminolide in RAW264.7 cells and HUVECs: involvement of MAPK and NF-κB pathways.

Authors:  Mouna Achoui; Karen Heyninck; Chung Yeng Looi; Ali Mohd Mustafa; Guy Haegeman; Mohd Rais Mustafa
Journal:  Drug Des Devel Ther       Date:  2014-10-20       Impact factor: 4.162

6.  Nickel sensitization and dietary nickel are a substantial cause of symptoms provocation in patients with chronic allergic-like dermatitis syndromes.

Authors:  Andrea Antico; Roberto Soana
Journal:  Allergy Rhinol (Providence)       Date:  2015-03-05

Review 7.  Pathogenesis of chronic urticaria: an overview.

Authors:  Sanjiv Jain
Journal:  Dermatol Res Pract       Date:  2014-07-10

8.  MCP-1-induced histamine release from mast cells is associated with development of interstitial cystitis/bladder pain syndrome in rat models.

Authors:  Jianwei Lv; Yiran Huang; Shiguo Zhu; Ganggang Yang; Yujian Zhang; Jing Leng; Juanjie Bo; Dongming Liu
Journal:  Mediators Inflamm       Date:  2012-09-19       Impact factor: 4.711

9.  Relationship between pre-implant interleukin-6 levels, inflammatory response, and early outcome in patients supported by left ventricular assist device: a prospective study.

Authors:  Raffaele Caruso; Luca Botta; Alessandro Verde; Filippo Milazzo; Irene Vecchi; Maria Giovanna Trivella; Luigi Martinelli; Roberto Paino; Maria Frigerio; Oberdan Parodi
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

10.  Neuronal Dual Leucine Zipper Kinase Mediates Inflammatory and Nociceptive Responses in Cyclophosphamide-Induced Cystitis.

Authors:  Chen Jiang; Weilin Fang; Tingting Lv; Yinjun Gu; Jianwei Lv
Journal:  J Innate Immun       Date:  2021-06-25       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.